Journal of Osteoporosis is a leading open-access journal dedicated to the investigation and dissemination of research in the field of osteoporosis and related bone disorders. Published by HINDAWI LTD, the journal has been fostering academic discourse since 2010, ensuring that critical findings are accessible to researchers, clinicians, and policy-makers alike. With an ISSN of 2090-8059 and an E-ISSN of 2042-0064, it serves as a significant platform for advancing knowledge in Endocrinology, Diabetes, and Metabolism, currently holding Q4 and Q3 categorizations in respective quartiles as of 2023. The journal, which publishes annually and is based in the United States, plays a crucial role in documenting the evolving understanding of bone health, contributing to improved clinical practices and patient outcomes. As it converges insights from diverse fields, it is an essential resource for researchers aiming to impact the future of osteoporosis management and treatment.

Journal of Clinical and Translational Endocrinology is a peer-reviewed open access journal published by Elsevier that has been serving the endocrinology community since its inception in 2014. With an ISSN of 2214-6237, this journal focuses on the critical intersection of clinical and translational research in endocrinology, diabetes, and metabolism, offering insights that bridge laboratory discoveries with patient care. It holds a commendable position in the field, ranking Q3 for Endocrinology and Q2 for Endocrinology, Diabetes, and Metabolism, reflecting its rigorous standards and relevance to contemporary research. Situated in the Netherlands, the journal’s aim is to foster knowledge dissemination and collaboration among professionals, researchers, and students alike, ensuring high visibility in a rapidly evolving field. The journal is committed to open access, allowing immediate access to research findings, thus maximizing their impact and facilitating advancements in clinical practice and research. With an H index that showcases its contribution to the field, Journal of Clinical and Translational Endocrinology is an essential resource for anyone invested in advancing endocrinological science.

JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION, published by SPRINGER, is a leading peer-reviewed journal dedicated to advancing the field of endocrinology. With a remarkable history dating back to 1978 and a convergence set until 2024, this journal serves as a vital source for researchers, clinicians, and students focusing on the intricate interplay of hormonal regulation and its implications for health and disease. The journal is recognized in the Q2 category for both Endocrinology and Endocrinology, Diabetes and Metabolism, highlighting its relevance and impact within the scientific community, exemplified by its strong Scopus rankings. While it does not offer open access, it ensures that high-quality research, reviews, and significant clinical findings are accessible to its readership. With a commitment to improving patient outcomes and elucidating complex biological mechanisms, the JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION remains a cornerstone publication for anyone involved in the study or practice of endocrinology.

The JOURNAL OF ORTHOPAEDIC RESEARCH, published by WILEY, stands as a premier peer-reviewed journal in the field of orthopedics and sports medicine, showcasing high-impact research with a notable impact factor and categorized in the top Q1 quartile for 2023. Since its inception in 1983, this journal has continuously evolved to meet the needs of a dynamic scientific community, serving as a vital resource for researchers, clinicians, and students engaged in the study and practice of orthopedics. With commendable rankings, positioned at Rank #47 out of 321 in the Medicine Orthopedics and Sports Medicine category, and boasting a remarkable 85th percentile in Scopus rankings, it highlights groundbreaking studies and advances in orthopedic science. While not an open-access journal, it provides diverse access options to ensure that its contributions are available to a broad academic audience. The journal plays a crucial role in disseminating innovative ideas and fostering collaboration within the orthopedic research community, thereby promoting improved patient care and outcomes in musculoskeletal health.

Current Osteoporosis Reports, published by Springer, is a premier journal dedicated to advancing the understanding of osteoporosis and related metabolic bone diseases. With its ISSN 1544-1873 and E-ISSN 1544-2241, this esteemed publication has established itself as a vital resource in the field of endocrinology, diabetes, and metabolism, evidenced by its Q1 ranking and 82nd percentile in Scopus. Spanning from 2003 to 2024, the journal seeks to disseminate high-quality research, critical reviews, and comprehensive reports that address the complexities of osteoporosis, offering insights into diagnosis, treatment, and prevention strategies. Although not an open-access journal, Current Osteoporosis Reports ensures that researchers, healthcare professionals, and students have access to cutting-edge scientific knowledge that fuels innovative approaches to improving patient care and outcomes. The journal's impact in shaping the dialogue and research landscape in its domain underscores its importance for anyone invested in improving bone health.

JOURNAL OF BONE AND MINERAL METABOLISM, published by SPRINGER JAPAN KK, is a leading peer-reviewed journal dedicated to advancing the field of bone and mineral research since its establishment in 1988. With ISSN 0914-8779 and E-ISSN 1435-5604, this esteemed journal offers a platform for high-quality research that intersects Endocrinology, Diabetes and Metabolism, Orthopedics and Sports Medicine, and related disciplines. Recognized for its rigorous standards, it holds a commendable Q2 ranking in multiple categories, reflecting its broad influence and relevance in contemporary medical research. Researchers and practitioners alike benefit from its evidence-based articles and insights, which contribute significantly to our understanding of metabolic bone diseases and mineral homeostasis. Although not an open-access journal, it still provides essential information and advancements crucial for professionals and scholars dedicated to improving clinical outcomes and enhancing patient care in these vital areas. To learn more, please explore the journal's archives and latest publications.

Clinical Oral Implants Research, published by Wiley, is a premier journal dedicated to the field of oral surgery and implantology. Established in 1990, this influential journal has rapidly ascended to the forefront of dental research, notable for its Q1 ranking in the Oral Surgery category and a remarkable 97th percentile ranking among 74 journals in Dentistry- Oral Surgery, according to Scopus metrics. The journal aims to disseminate cutting-edge research findings, innovative techniques, and comprehensive reviews that fundamentally enhance understanding and practice in dental implants. With a commitment to fostering collaboration and knowledge-sharing among professionals, researchers, and students, Clinical Oral Implants Research plays a vital role in advancing the scientific community's grasp of implant dentistry and improving patient outcomes on a global scale. While it operates under traditional subscription access, it continues to attract a diverse readership interested in the latest advancements and strategies in oral implant research.

OSTEOPOROSIS INTERNATIONAL, published by SPRINGER LONDON LTD, stands at the forefront of research in the field of bone health and metabolic disorders, specifically focusing on osteoporosis and related conditions. With an ISSN of 0937-941X and impressive ranking in the Q1 category of both Endocrinology, Diabetes and Metabolism, and Medicine (miscellaneous) for 2023, this journal ranks 47th out of 244 in its category, placing it solidly within the top 20% of its field, according to Scopus metrics. The journal, active since 1990, aims to foster a deep understanding of osteoporosis through high-quality research articles, reviews, and clinical insights that are pivotal for healthcare professionals, researchers, and students alike. Although it does not offer open access, users can expect rigorous peer-reviewed content that significantly contributes to the advancement of knowledge in osteoporosis prevention, diagnosis, and treatment. With a dedicated readership and a commitment to excellence, OSTEOPOROSIS INTERNATIONAL plays a vital role in shaping the future of bone health research.

Bone Research is a premier open-access journal published by SpringerNature, dedicated to advancing the understanding of bone biology and its related disciplines. Established in 2013 and based in the United Kingdom, this journal has quickly ascended to the forefront of scientific inquiry, evidenced by its esteemed Q1 rankings in 2023 across multiple categories including Endocrinology, Diabetes and Metabolism, Histology, and Physiology. With a commendable impact reflected in its Scopus ranks—positioned #2 in Histology, #9 in Endocrinology, and #8 in Physiology—Bone Research serves as a vital platform for researchers, healthcare professionals, and students alike to share and access cutting-edge findings. Since adopting an open-access model in 2014, the journal has empowered an expansive audience by facilitating immediate availability of high-quality research. This aligns with its commitment to foster innovation and collaboration within the fields it encompasses. As it converges its efforts from 2013 to 2024, Bone Research remains a critical resource for those looking to deepen their investigation into bone health and diseases, ensuring its place as a leader in promoting scientific excellence.

Osteoporosis and Sarcopenia is a leading journal dedicated to the multidisciplinary exploration of diseases related to bone health and muscle degeneration, published by Elsevier. With an ISSN of 2405-5255 and an E-ISSN of 2405-5263, this open-access journal has been a vital resource since its inception in 2015, enabling unrestricted access to groundbreaking research. Its objective is to elucidate the interplay between osteoporosis and sarcopenia, offering valuable insights into diagnostics, treatment strategies, and preventive measures in the field. The journal serves as a crucial platform for researchers, healthcare professionals, and students, fostering collaboration and innovation in understanding these prevalent conditions. Given the global rise in aging populations, the significance of this journal cannot be overstated, making it an essential reference for those committed to advancing knowledge in musculoskeletal health.